Pharmacological and In Silico Analysis of Oat Avenanthramides as EGFR Inhibitors: Effects on EGF-Induced Lung Cancer Cell Growth and Migration

Int J Mol Sci. 2022 Aug 1;23(15):8534. doi: 10.3390/ijms23158534.

Abstract

Avena sativa L. is a wholegrain cereal and an important edible crop. Oats possesses high nutritional and health promoting values and contains high levels of bioactive compounds, including a group of phenolic amides, named avenanthramides (Avns), exerting antioxidant, anti-inflammatory, and anticancer activities. Epidermal growth factor receptor (EGFR) represents one of the most known oncogenes and it is frequently up-regulated or mutated in human cancers. The oncogenic effects of EGFR include enhanced cell growth, angiogenesis, and metastasis, and down-regulation or inhibition of EGFR signaling has therapeutic benefit. Front-line EGFR tyrosine kinase inhibitor therapy is the standard therapy for patients with EGFR-mutated lung cancer. However, the clinical effects of EGFR inhibition may be lost after a few months of treatment due to the onset of resistance. Here, we showed the anticancer activity of Avns, focusing on EGFR activation and signaling pathway. Lung cancer cellular models have been used to evaluate the activity of Avns on tumor growth, migration, EMT, and anoikis induced by EGF. In addition, docking and molecular dynamics simulations showed that the Avns bind with high affinity to a region in the vicinity of αC-helix and the DGF motif of EGFR, jeopardizing the target biological function. Altogether, our results reveal a new pharmacological activity of Avns as EGFR tyrosine kinase inhibitors.

Keywords: EGFR; avenanthramide C; avenanthramides; classical molecular dynamics simulation; docking simulation; lung cancer; steered molecular dynamics simulation.

MeSH terms

  • Avena* / chemistry
  • Cell Line, Tumor
  • Edible Grain / chemistry
  • Epidermal Growth Factor
  • ErbB Receptors / analysis
  • ErbB Receptors / genetics
  • Humans
  • Lung Neoplasms* / drug therapy
  • Protein Kinase Inhibitors / pharmacology
  • ortho-Aminobenzoates

Substances

  • Protein Kinase Inhibitors
  • ortho-Aminobenzoates
  • avenanthramide-2C
  • Epidermal Growth Factor
  • EGFR protein, human
  • ErbB Receptors